Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Cannabis

Meta-analysis fails to find evidence that medical marijuana influences quality of life

by Eric W. Dolan
April 10, 2017
in Cannabis, Psychopharmacology
A marijuana bud. (Photo credit: Dank Depot)

A marijuana bud. (Photo credit: Dank Depot)

Share on TwitterShare on Facebook

New research indicates that marijuana has no impact on quality of life when used for many medical conditions. The findings appear in the peer-reviewed scientific journal Drug and Alcohol Dependence.

The researchers conducted a meta-analysis — a method of statistically examining previous research — of eleven scientific studies on cannabis or cannabinoids and quality of life. The meta-analysis failed to find a significant association between use of cannabis or cannabinoids and quality of life among those with medical conditions.

PsyPost interviewed one of the study’s authors, Itai Danovitch of Cedars-Sinai Medical Center in Los Angeles. Read his responses below:

PsyPost: Why were you interested in this topic?

Danovitch: Many cannabis users report that cannabis makes them feel better, that it improves their sense of wellbeing. One good scientific measure of wellbeing is “Quality of Life,” a person-centered indicator that measures perceptions about physical and mental health. We were interested to learn whether people using cannabis for medical conditions experienced significant changes in Quality of Life.

What should the average person take away from your study?

We did not find a clear association between cannabis use and Quality of Life. There were some indications of a positive association among studies that evaluated the effects of cannabis on pain, and other studies that failed to find any association. So, while cannabis may help alleviate symptoms of several medical conditions, at this point in time there is not convincing evidence that those effects lead to significant improvements in Quality of Life.

Are there any major caveats? What questions still need to be addressed?

Google News Preferences Add PsyPost to your preferred sources

Well, our study was a “meta-analysis,” which means it was a study of other studies. Only eleven studies met the standards we set, which limited our ability to make broad inferences about the effects of cannabis and Quality of Life. The studies had a great deal of variability, and since they were mostly designed to evaluate the effect of cannabis on medical conditions, it was difficult to disentangle whether changes in Quality of Life were attributable to those medical conditions, or to the cannabis itself. However, as more and more people are using cannabis on a regular basis to help with medical conditions, it is incumbent on us to understand the objective and subjective effects of cannabis over time.

Is there anything else you would like to add?

Cannabis is a complex herb that has many active constituents and exciting therapeutic potential. However, use of cannabis for medical indications is growing faster than the supporting evidence. And because cannabis can cause mild euphoria, it is difficult to separate its pleasurable effects from its therapeutic effects. It is important to scrutinize any medication, supplement or herb that is taken on a long-term basis for a health condition. And measuring Quality of Life is a particularly important way to evaluate the factors people care about most.

The study, “The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis“, was also co-authored by Matthew Goldenberg, Mark William Reid, and Waguih William IsHak.

Previous Post

Study on women and their moms finds physical attractiveness takes priority over personality

Next Post

Study suggests perceived pornography addiction can harm relationships even if pornography itself does not

RELATED

Does psilocybin really provide long-term relief from depression, as new study suggests?
Psilocybin

Psilocybin slows down human reaction times and impairs executive function during the acute phase of use

April 5, 2026
Psychedelic experiences linked to long-term improvements in psychological flexibility, study finds
Psilocybin

Can a psychedelic journey change what you value most?

April 4, 2026
Cannabis intoxication broadly impairs multiple memory types, new study shows
Cannabis

Cannabis intoxication broadly impairs multiple memory types, new study shows

April 3, 2026
Paternal psychological strengths linked to lower maternal inflammation in married couples
Depression

Scientists identify a brain signal that reveals whether depression therapies will work

April 2, 2026
AI autocomplete suggestions covertly change how users think about important topics
Alcohol

Smoked cannabis reduces immediate alcohol consumption in controlled laboratory trial

April 2, 2026
Lifting weights can slow down biological brain aging in older adults
Ayahuasca

Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder

March 31, 2026
Exposure to conspiracy theories heightens paranoid thoughts, study finds
Cannabis

Cannabis use exacerbates paranoia in survivors of chaotic childhoods, new study suggests

March 29, 2026
Distinct neural pathways link fear of missing out and negative emotions to compulsive phone use
Cannabis

Co-occurring depression and cannabis use linked to less efficient brain networks

March 28, 2026

STAY CONNECTED

RSS Psychology of Selling

  • New research reveals the “Goldilocks” age for social media influencers
  • What today’s shoppers really want from salespeople, and what drives them away
  • The salesperson who competes against themselves may outperform the one trying to beat everyone else
  • When sales managers serve first, salespeople stay longer and sell more confidently
  • Emotional intelligence linked to better sales performance

LATEST

People consistently devalue creative writing generated by artificial intelligence

Psilocybin slows down human reaction times and impairs executive function during the acute phase of use

Psychological traits of scientists predict their theories and research methods

“Falling back” makes us more miserable than “springing forward,” new study finds

The psychology of schadenfreude: an opponent’s suffering triggers a spontaneous smile

The four types of dementia most people don’t know exist

Are women more likely to regret one-night stands? Only when they sleep with men

Higher testosterone linked to increased suicide risk in depressed teenage boys

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc